24 HR tramadol hydrochloride 150 MG Extended Release Oral Capsule

1 INDICATIONS AND USAGE Tramadol Hydrochloride Extended-Release is indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time. Tramadol Hydrochloride Extended-Release is an opioid agonist indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time. ( 1 )

Aidarex Pharmaceuticals LLC

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] fatigue` `[3] pain` `[4] nausea` `[5] diarrhoea` `[6] dyspnoea` `[7] headache` `[8] dizziness` `[9] arthralgia` `[10] off label use`

2 years ago

CAPSULE WHITE G322 150

2 years ago

G322 150 CAPSULE WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING Tramadol Hydrochloride Extended-Release capsules are supplied as opaque white hard gelatin capsules, imprinted as follows. 150 mg capsules: white capsule imprinted with gold ink “ G 322 ” on cap and “ 150 ” between lines on the body Bottle of 30 capsules: NDC 33261-0880-30 Bottle of 60 capsules: NDC 33261-0880-60 Bottle of 90 capsules: NDC 33261-0880-90 Storage Dispense in a tight container. Store at 25°C; excursions permitted to 15°C to 30°C (59°F to 86°F). Keep out of reach of children. Distributed by: KLE 2 Inc. Culver City, CA 90232 Repacked By: Aidarex Pharmaceuticals, LLC Corona, CA 92880

More pills like CAPSULE G322 150

Related Pills

tramadol hydrochloride 150 mg

aidarex pharmaceuticals llc

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site